Prof. Abraham Thomas

Henry Ford Hospital, USA

Email: athomas3@hfhs.org

Qualifications

2004 M.P.H., Harvard School of Public Health, USA

1989 M.D., Columbia University, USA

1985 A.B., Columbia University, USA

Publications (Selected)

1. Bing Wang1, Rickey E Carter1, Miran A Jaffa1,2, Sashidhar Nakerakanti1, Daniel Lackland1, Maria Lopes-Virella1, Maria Trojanowska1, Louis M Luttrell1, Ayad A Jaffa1,3The DCCT/EDIC Study Group. Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet 2010; 47:391-397.
2. Miller, ME, Bonds DE, Gerstein, HC, et.al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.BMJ 2010;340:b5444.
3. White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD; DCCT-EDIC Research Group. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010 May;59(5):1244-53. Epub 2010 Feb 11.
4. The ACCORD Study Group. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 2010; 362:1575-1585 April 29, 2010.
5. Matthew C. Riddle, MD1, Walter T. Ambrosius, PHD2, David J. Brillon, MD3, et al. for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators* Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD TrialDiabetes Care May 2010 vol. 33 no. 5 983-990.
6. Richard L. Kleina, b, Rickey E. Carterc, Alicia J. Jenkinsa, d, e, Timothy J. Lyonse, Nathaniel L. Bakerc, Gregory E. Gilbertc, Gabriel Virellaf, Maria F. Lopes-Virellaa, b and the DCCT/EDIC Research Groupg LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses. Journal of Diabetes and its Complications. Available online June 2010.
7. Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth S, Grimm RH, Corson MA, Prineas R; Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010 Jul;33(7):1578-84.
8. Faramarz. Ismail-Beigi, Timothy. Craven, Mary Ann. Banerji, Jan. Basile, Jorge. Calles, Robert M. Cohen, Robert. Cuddihy, William C. Cushman, Saul. Genuth, Richard H. Grimm Jr, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. The Lancet, Volume 376, Issue 9739, Pages 419-430, August 7, 2010.
9. Aruna V. Sarma, Alka M. Kanaya, Leroy M. Nyberg, John W. Kusek, Eric Vittinghoff, Brandy Rutledge, Patricia A. Cleary, Patricia Gatcomb, Jeanette S. Brown, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Urinary Incontinence among Women with Type 1 Diabetes: How common is it? Journal of Urology, 2009, 181:1224-1230.
10. C.A. Czaja, B.N. Rutledge, P.A. Cleary, K. Chan, A.E. Stapleton, W.E. Stamm, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort. Journal of Urology, 2009, 181:1129-1135.
11. Rodica Pop-Busui, MD, PhD; Phillip A. Low, MD; Barbara H. Waberski, MS; Catherine L. Martin, MS; James W. Albers, MD, PhD; Eva L. Feldman, MD, PhD; Catherine Sommer; Patricia A. Cleary, MS; John M. Lachin, ScD; William H. Herman, MD, MPH, for the DCCT/EDIC Research Group. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus.The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC). Circulation. 2009;119:2886-2893.
12. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH, Bochenski J, Waggott D, Merchant ML, Krolewski B, Mirea L, Wanic K, Katavetin P, Kure M, Wolkow P, Dunn JS, Smiles A, Walker WH, Boright AP, Bull SB; DCCT/EDIC Research Group, Doria A, Rogus JJ, Rich SS, Warram JH, Krolewski AS. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes. 2009 Jun;58(6):1403-10. Epub 2009 Feb 27.